The SELECT trial (published in NEJM 2023) established semaglutide's cardiovascular benefits in patients with established cardiovascular disease and overweight or obesity but without diabetes
Patients benefit from a clinician who has guided thousands of individuals through both surgical and non-surgical weight management, providing a comprehensive perspective that few programs can match
Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes
Just keep in mind that many of its ingredients, like horsetail and methylsulfonylmethane (MSM), need more robust studies to confirm their effectiveness
Specifically, this tail forms a Trp cage at the C-terminus, which protects the peptide from degradation by another protease, neutral endopeptidase (NEP)
In the periphery, both in vivo and in vitro studies have demonstrated that GIP binding to its receptor (GIPR) increases intracellular cAMP levels in pancreatic -cells, thereby activating PKA
